Listed by the USPTO as OLSON, ANDREA STEFFEL
Tech Center 3700 • Art Units: 1623 1656 1673 1693 3762
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18449862 | PROCESS FOR THE DE-TRITYLATION OF OLIGONUCLEOTIDES | Final Rejection | Hoffmann-La Roche Inc. |
| 18714020 | METHOD FOR PRODUCING DISACCHARIDE USING BETA-GLUCOSIDASE AND COFACTOR THEREOF AND COMPOSITION FOR INDUCING ENZYME PRODUCTION OF STRAIN OF GENUS TRICHODERMA COMPRISING PRODUCED DISACCHARIDE | Non-Final OA | CJ CheilJedang Corporation |
| 17904211 | LONG CHAIN CARBON AND CYCLIC AMINO ACIDS SUBSTRATES FOR GENETIC CODE REPROGRAMMING | Final Rejection | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
| 18017306 | METHOD FOR MODULATING THE BLADDER MICROBIOME TO IMPROVE BLADDER HEALTH | Non-Final OA | Kimberly-Clark Worldwide, Inc. |
| 18839102 | Compounds for Anti-aging Intervention | Non-Final OA | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 18713342 | FLAVANOID CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF MITOCHONDRIAL DISORDERS | Non-Final OA | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 18687785 | CONJUGATES, COMPOSITIONS, AND METHODS FOR REJUVENATION OF CAR T-CELLS | Non-Final OA | Purdue Research Foundation |
| 18410094 | METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION | Non-Final OA | ASTRAZENECA AB |
| 18232909 | QUINONE METHIDE ANALOG SIGNAL AMPLIFICATION | Final Rejection | Ventana Medical Systems, Inc. |
| 18646814 | APPLICATION OF TYPHANEOSIDE IN PREPARATION OF MEDICINE FOR URIC ACID-LOWERING AND/OR KIDNEY INJURY | Non-Final OA | Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences |
| 18616904 | CATALYTIC POLYMERIZATION AND DEPOLYMERIZATION OF 1,6-ANHYDROSUGARS | Final Rejection | The Trustees of Boston College |
| 18740235 | METHODS OF USING COMPOUND OF GLYCOSAMINOGLYCAN | Non-Final OA | Holy Stone Healthcare Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy62.6% of resolved applications examined by Andrea Steffel Olson were allowed (1,434 resolved cases), compared with 51.0% across Art Unit 1623 over the last five years.
This examiner's interview lift is -11.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Andrea Steffel Olson took 1,153 days on average from filing to allowance.
Andrea Steffel Olson examines applications in Art Unit 1623 in Tech Center 3700 (Medical Devices & Mechanical Engineering).